Ampliqon is a global leader in production of PCR Enzymes and custom made laboratory reagents.

baSeq is developing intuitive LLM-based software to streamline the analysis of complex biological data, making specialist knowledge superfluous and lowering the cost of scRNA-seq research.

Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population.

Benchling is a cloud-based platform for biotechnology research and development.

Unleash the full potential of your nucleic acid technology!

BioSpring is a leading industry expert in oligonucleotide science and technology, specializing in high-quality cGMP manufacturing and analytics for commercial programs and clinical phases I-III, in addition to preclinical material supply and diagnostic manufacturing. We are a privately owned company of 555 employees committed to providing expert support through all phases and regulatory filings, including highly flexible and customizable solutions to accelerate therapeutic programs through the entire drug development lifecycle. Our global clients rely on our quality and expertise, guided by our passion for innovation and over 26 years of experience.

Broken String Bioscience’s technology platform, INDUCE-seq, supports the development of cell and gene therapies that are safer by design. INDUCE-seq™, is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes. The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs.

CasCure is developing personalised cancer treatment technology by utilising the effect of cell death caused by multiple DNA damage, with CRISPR technology that can selectively attack cancer cell-specific genetic mutations.

Cellecta Inc., a trusted provider of genomic products and services, has successfully collaborated with the world’s leading pharma, biotech, government, and academic institutions to drive drug target and biomarker discovery since 2006. Our recognized expertise in viral vector production, functional screening, cell engineering and multiplex qRT-PCR has given rise to a portfolio of offerings useful for loss-of-function and gain-of-function phenotypic screening, cell barcoding, cell engineering, targeted RNA-Seq expression, adaptive immune receptor profiling, and much more.

ChemoMetec is a leading manufacturer of high-precision cell counting and analysis equipment.

Our robust Xcytomatic® and NucleoCounter® instruments are the most precise automated cell counters on the market and enable the development of reproducible processes and cGMP manufacturing of biological products.

The stellar support we offer from our field application scientists and engineers help thousands of biopharma customers integrate commercial-ready cell counting processes across sites. No matter the sample, location or user, our technology ensures consistent performance.

Clean Cells is a subsidiary of Clean Biologics. It offers (i) quality control and biological safety tests for biopharmaceutical products to assist in regulatory compliance, production of cell banks and GMP-grade BSL2 virus seed stock, supply of secure storage for these products and development and validation of bespoke analysis tools. The company was created in 2000 when three biologists from the Aventis-Institut de France Foundation sought to offer innocuity testing for biopharmaceuticals. Clean Cells is now one of the largest European companies within this sector. Its strong customer focus and sizable product catalog (which expands annually) have made it a key player in the development of novel treatments and in personalized medicine. Clean Cells also stands out for its ability to react and adapt to its customers’ needs and the transparency of its production and quality control processes. Based near Nantes, in Western France, Clean Cells employs 133 staff.

Countagen develops quality control tools for gene editing methods to enable and accelerate research and development.

Biomolecular research
Stem cells applications
Blood group specific human polyclonal antibodies

EW Lab

Frontiers’ mission is to make science open - so that scientists can collaborate better and innovate faster to deliver the solutions that enable healthy lives on a healthy planet. This event is sponsored by Frontiers in Genome Editing, a multidisciplinary journal that explores innovations in, and the applications of, genome and epigenome editing technologies within human health, animal science, and plant science. Frontiers in Genome Editing is committed to advancing developments in the field by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future.

Full Circles Therapeutics is transforming viral free genome surgery platform to treat severe genetic disease and cancer worldwide.

GenScript Biotech Corporation is the world’s leading technology and service provider of life science R&D and manufacture.
GenScript Biotech offers comprehensive gene synt
hesis, DNA and RNA oligo synthesis with specialties in CRISPR sgRNA/NGS/qPRC/ tRNA/siRNA oligos, IVT mRNA/circRNA synthesis and LNP formulation, as well as peptide synthesis, protein and antibody production services. GenScript Biotech can also offer peptides as well as CRISPR services from research use to cGMP needs.
Driven by the corporate mission of “make people and nature healthier through biotechnology”, GenScript Biotech strives to become the most trustworthy biotech company in the world.

For more than 35 years, Integrated DNA Technologies, Inc. (IDT) has been empowering genomics laboratories with an oligonucleotide manufacturing process unlike anyone else in the industry, with the most advanced synthesis, modification, purification, and quality control capabilities available. Since its founding in 1987, IDT has progressed from a leading oligo manufacturer to a genomics solutions provider supporting key application areas such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference. Through its GMP* services, IDT manufactures products used by scientists researching many forms of cancer and most inherited and infectious diseases. As the company seeks to fulfill its mission of accelerating the pace of genomics, the important acquisition of Archer™ NGS Research Assays was completed in Dec. 2022. When combined with its existing solutions, the expanded portfolio helps realize the shared vision of enabling researchers to rapidly move from the lab to life-changing advances.

iotaSciences provides instrumentation to facilitate and simplify applications that require single-cell isolation, such as cell line development, genome editing and omics-based analyses. Using automated fluid handling, our single-cell isolation technology streamlines your experiments without the need for complex protocols and excessive manual handling. Our portfolio of scientific instruments deliver powerful automation, high single-cell isolation efficiency and viability, as well as documented proof of single-cell isolation with image-capture capabilities. We additionally operate an efficient and streamlined genome-editing pipeline for iPSCs and provide professional services for bespoke genome editing projects, combining our expertise in both CRISPR-Cas technologies and single-cell isolation.

MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery and commercialization of next-generation cell therapeutics. MaxCyte builds best-in-class technology to facilitate complex engineering of a variety of cells. Let’s Build Better Cells Together.

Mission Bio is a life sciences company that accelerates discoveries and cures for a wide range of diseases by equipping researchers with the tools they need to better measure, characterize, and predict our resistance and response to new therapies. Mission Bio’s multi-omics approach improves time-to-market for new therapeutics, including innovative cell and gene therapies that provide new pathways to health. The company’s Tapestri Platform is being utilized by customers at leading research centers, pharmaceutical, and diagnostics companies worldwide. A Tapestri assay recently entered GMP qualification and validation, indicating that single-cell analysis is on its way to routine use in clinical trials to support the next wave of life-saving CGT treatments.

Moligo Technologies produce ultrapure DNA molecules with unprecedented length, complexity and scale, to enable all cell and gene therapies and technologies.

OLS OMNI Life Science is your partner in Cell Research, based on our strong portfolio of own-produced instruments in Germany, as well as from selected global partners combined with our deep cell research understanding. Brands; CASY Label-free cell counter, CERO incubator, CellRaft AIR, WiScan, TIGR and consumables from HiMedia.

RadaHaim is transforming medicine with its organoid mass production platform, focused on standardizing its development. Our cutting-edge technology enables consistent, scalable production of high-quality organoids, facilitating advanced research and therapeutic applications in a diverse range of medical fields.

Samplix ApS supports research into new gene and cell therapies with microfluidics-based solutions that deliver high-resolution insights into genomes and cells. Samplix products, Xdrop and Xdrop Sort, can encapsulate DNA fragments in double-emulsion droplets, for highly precise investigations of CAR cassette insertions, on- and off-target CRISPR edits, and more. They can also encapsulate living cells for single-cell functional analyses, such as cytokine secretion and cell-killing assays. Xdrop and Xdrop Sort offer a huge boost to gene and cell therapy research.

SciLifeLab is a world-leading Swedish national center for large-scale research and one of the largest molecular biology research laboratories in Europe at the forefront of innovation in life sciences.

ST Pharm is a technology-driven CDMO, specializing in the development, manufacturing, and commercialization of oligonucleotides (including sgRNA), mRNA, and small molecule APIs. ST Pharm has firmly established itself as a leading global provider of oligonucleotide APIs. Leveraging its profound know-hows in development and manufacturing of nucleotides and oligonucleotides, ST Pharm expanded its business scope to mRNA CDMO, utilizing its own mRNA platform technology, and sgRNA CDMO. To learn more about ST Pharm, visit www.stpharm.co.kr or follow ST Pharm on LinkedIn.

Synthego offers Full Stack Genome Engineering Solutions from synthetic sgRNAs and RNP, CRISPR-KO cell line to GMP grade CRISPR reagents.

VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside.

Vivlion offers PRCISR™ CRISPR screening solutions to advance research in functional genomics and drug discovery. Vivlion's 3Cs technology enables the production of uniformly distributed gRNA libraries in single or combinatorial format. Solutions range from pooled and arrayed gRNA libraries to customised screening services and bioinformatic analyses

CRISPR cell based functional assays supporting drug target development and patient stratification. Experts on acquired drug resistance. More info.

ZeClinics is a CRO using zebrafish for creating genetic models and testing both safety and efficacy of novel chemicals. We combine our technical expertise with a diversified portfolio to reduce by 10-fold our clients' time and cost requirements. Our services range from HTS screenings, cutting-edge CRISPR/cas9 gene-editing and phenotypic models in different therapeutic areas: ophthalmology, metabolic, muscular and CNS. The company has a global reach and flexible approach with corporate and academic clients across 4 continents. As leading CRISPR-licensed CRO, our expertise allows developing custom zebrafish genetic models to mimic human disease and performing functional genomic and target validation.